According to Nektar Therapeutics 's latest financial reports the company's total assets are HK$2.36 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | HK$2.35 B | -24.12% |
2023-12-31 | HK$3.10 B | -44.01% |
2022-12-31 | HK$5.55 B | -36.27% |
2021-12-31 | HK$8.71 B | -26.97% |
2020-12-31 | HK$11.92 B | -22.54% |
2019-12-31 | HK$15.39 B | -8.54% |
2018-12-31 | HK$16.83 B | 323.51% |
2017-12-31 | HK$3.97 B | -9.87% |
2016-12-31 | HK$4.41 B | 14.14% |
2015-12-31 | HK$3.86 B | 12.83% |
2014-12-31 | HK$3.42 B | 1.66% |
2013-12-31 | HK$3.36 B | -12.67% |
2012-12-31 | HK$3.85 B | -18.1% |
2011-12-31 | HK$4.71 B | 16.14% |
2010-12-31 | HK$4.05 B | -9.1% |
2009-12-31 | HK$4.46 B | 3.02% |
2008-12-31 | HK$4.33 B | -23.38% |
2007-12-31 | HK$5.65 B | -5.37% |
2006-12-31 | HK$5.97 B | -10.25% |
2005-12-31 | HK$6.65 B | 14.99% |
2004-12-31 | HK$5.78 B | 21.09% |
2003-12-31 | HK$4.78 B | 1.06% |
2002-12-31 | HK$4.73 B | -9.07% |
2001-12-31 | HK$5.20 B |